TLR4 and metabolic dysfunction-associated steatohepatitis: As shown in Figure 5, TLR4 positivity increased significantly in the NASH group when compared with the control group (45.00 ± 4.00 vs. 5.00 ± 2.00, respectively; p < 0.05).